R. Improgo

Whole-genome sequencing reveals activation-induced cytidine deaminase signatures during indolent chronic lymphocytic leukaemia evolution

S. Gabriel, E. Lander, G. Getz, 2015, Nature Communications.

High-Throughput Quantitative Assay Technologies for Accelerating the Discovery and Optimization of Targeted Protein Degradation Therapeutics

R. Improgo, S. Fisher, R. Pollock, 2021, SLAS discovery : advancing life sciences R & D.

Survival of Del17p CLL Depends on Genomic Complexity and Somatic Mutation

G. Getz, Charles Lee, S. Kasar, 2016, Clinical Cancer Research.

Effect Of MYD88 Mutation In CLL On IRAK4 and BTK Inhibition In Vitro

N. Pochet, D. Neuberg, R. Improgo, 2013 .

Inhibition of the Notch1 Pathway in Chronic Lymphocytic Leukemia Promotes Apoptosis and Inhibits Proliferation

R. Improgo, S. Fernandes, Jennifer R. Brown, 2014 .